Our Vision is to Leverage the Oncotype DX Platform to be a Leading Provider of Genomic Information
Genomic Health, Inc. (NASDAQ: GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions.
Multigene Expression Tests - Diagnostic tests for cancer allowing physicians and patients to make individualized treatment decisions.
The pioneering work of Genomic Health in molecular diagnostics has led to the commercialization of clinically validated assays (tests) that provide individualized tumor information for patients and physicians for consideration as they make important treatment decisions, to learn more about the Oncotype DX tests for breast & colon cancer, please call: (866) ONCOTYPE or visit www.oncotypeDX.com
Get more information about genomics and cancer online:
Learn more about Genomic Health, molecular diagnostics company.